Annette Tognela

Campbelltown, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Time toxicity associated with treatment of metastatic or unresectable gastro-oesophageal cancers in the second-line setting.

Time toxicity associated with treatment of metastatic or unresectable gastro-oesophageal cancers in the second-line setting.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: June 27, 2025

Real-World Survival Outcomes of Patients With High PD-L1 Advanced NSCLC Who Received Chemoimmunotherapy Versus Immunotherapy.

Real-World Survival Outcomes of Patients With High PD-L1 Advanced NSCLC Who Received Chemoimmunotherapy Versus Immunotherapy.

Journal: Asia-Pacific journal of clinical oncology

Published: June 18, 2025

Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial.

Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 16, 2024

NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma.

NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma.

Journal: Neuro-oncology advances

Published: October 16, 2023

Accuracy of oncologists' estimates of expected survival time in advanced cancer.

Accuracy of oncologists' estimates of expected survival time in advanced cancer.

Journal: JNCI cancer spectrum

Published: August 13, 2023

A comparison of the outcomes of pulmonary versus extrapulmonary extensive-stage small cell carcinoma.

A comparison of the outcomes of pulmonary versus extrapulmonary extensive-stage small cell carcinoma.

Journal: Internal medicine journal

Published: July 28, 2023

Utility of multigene panel next-generation sequencing in routine clinical practice for identifying genomic alterations in newly diagnosed metastatic nonsmall cell lung cancer.

Utility of multigene panel next-generation sequencing in routine clinical practice for identifying genomic alterations in newly diagnosed metastatic nonsmall cell lung cancer.

Journal: Internal medicine journal

Published: January 19, 2023

Patients' perception of the benefits of palliative systemic therapy for advanced cancer.

Patients' perception of the benefits of palliative systemic therapy for advanced cancer.

Journal: Internal medicine journal

Published: December 19, 2022

COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ Cancers.

COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ Cancers.

Journal: Vaccines

Published: July 22, 2022

Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia.

Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia.

Journal: Vaccines

Published: May 10, 2022

Outcomes of extensive stage extrapulmonary small cell cancer.

Outcomes of extensive stage extrapulmonary small cell cancer.

Journal: Internal medicine journal

Published: March 17, 2022

Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial.

Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: June 13, 2020

Showing 1-12 of 22

Last Updated: 09/26/2026